Chennai Meenakshi Multispeciality Hospital Ltd
BSE:523489
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (13.3), the stock would be worth ₹6.23 (84% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 83.8 | ₹39.2 |
0%
|
| 3-Year Average | 13.3 | ₹6.23 |
-84%
|
| 5-Year Average | 8.8 | ₹4.11 |
-90%
|
| Industry Average | 83 | ₹38.82 |
-1%
|
| Country Average | 49.7 | ₹23.28 |
-41%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Chennai Meenakshi Multispeciality Hospital Ltd
BSE:523489
|
292.8m INR | 83.8 | -35.7 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.8B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.9B USD | 6.1 | 9.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.7B USD | 29.2 | 30.7 |
Market Distribution
| Min | 0.6 |
| 30th Percentile | 27.4 |
| Median | 49.7 |
| 70th Percentile | 92 |
| Max | 57 010.1 |
Other Multiples
Chennai Meenakshi Multispeciality Hospital Ltd
Glance View
Chennai Meenakshi Multispeciality Hospital Ltd. operates as a hospital, which provides healthcare services. The company is headquartered in Chennai, Tamil Nadu. The firm operates an approximately 100-bedded hospital located at Mylapore. The firm's services include cardiology, cosmetic and plastic surgery, diabetology, endocrinology, dermatology, dentistry, surgical gastroenterology, general surgery, gynecology, vascular surgery, minimal access general and metabolic tumors surgery, neurology, neuro surgery, orthopedics, pediatrics, pediatric gastroenterology, ophthalmology and pulmonology. The company also offers a range of programs, such as Basic Health Check Up, which include hematology and bio-chemistry; Master Health Check Up, which include hematology, bio-chemistry, lipid profile, general tests and liver function test (LFT), and Executive Health Check Up, which include hematology, bio-chemistry, renal profile, lipid profile, LFT and general tests.
